跳至主要内容
临床试验/NCT03804814
NCT03804814终止不适用

Assessing a Model for Hepatitis C Elimination: Measuring Patient and Health System Outcomes After Motivational Interviewing Interventions to Increase Treatment Engagement

Nova Scotia Health Authority1 个研究点 分布在 1 个国家目标入组 2 人开始时间: 2019年5月21日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
终止
入组人数
2
试验地点
1
主要终点
HCV Treatment Completion

研究概览

简要总结

This study addresses a difficult barrier to hepatitis C elimination, specifically development and maintenance of a productive relationship between the health care provider and patient to ensure both treatment success and engagement in harm reduction services. Improvements in these domains may be observed through the use of a technique called "Motivational Interviewing" (MI). The aim of this study is to determine whether a customized motivational interviewing curriculum by general primary care and addictions medicine primary care providers changes rates of curative hepatitis C therapy completion.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Other
盲法
None

入排标准

性别
All
接受健康志愿者
否

入选标准

  • •Patient Inclusion Criteria:
  • •Willingness to participate and provide informed consent
  • •Positive HCV RNA Result
  • •≥18 years of age

排除标准

  • •Unwilling or unable to provide consent
  • •Health Care Provider Inclusion Criteria:
  • •Willingness to participate and provide informed consent
  • •Has a hepatitis C care experience
  • •Health Care Provider Exclusion Criteria:
  • •Unwilling or unable to provide consent

研究组 & 干预措施

Motivational Interviewing Training

Active Comparator

Health care providers will be trained in motivational interviewing for use in Hepatitis C patient encounters.

干预措施: Motivational Interviewing Training (Behavioral)

Standard Clinical Encounter

No Intervention

Health care providers will not be trained in motivational interviewing for use in Hepatitis C patient encounters.

结局指标

主要结局

HCV Treatment Completion

时间窗: Through study completion, an average of 2 years

To measure the number of patients who complete HCV therapy

次要结局

  • Percentage of eligible individuals that initiate HCV therapy(Through study completion, an average of 2 years)
  • Self-reported intent to initiate and maintain HCV treatment assessed by questionnaire(Through study completion, an average of 2 years)
  • Number of unique Hepatitis C related and unrelated health system visits(Through study completion, an average of 2 years)
  • Time from care engagement to treatment initiation(Through study completion, an average of 2 years)
  • Number of scheduled and attended medical care appointments(Through study completion, an average of 2 years)
  • Time to complete prescribed HCV treatment course(Through study completion, an average of 2 years)
  • Healthcare provider knowledge, attitudes, and behavior about motivational interviewing and training assessed by questionnaire(Through study completion, an average of 2 years)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Lisa Barrett

Assistant Professor

Dalhousie University

研究点 (1)

Loading locations...

相似试验